J
J. Michael Collier
Researcher at Lawrence Berkeley National Laboratory
Publications - 13
Citations - 777
J. Michael Collier is an academic researcher from Lawrence Berkeley National Laboratory. The author has contributed to research in topics: Radiation therapy & Gene. The author has an hindex of 11, co-authored 13 publications receiving 752 citations. Previous affiliations of J. Michael Collier include University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Positive and negative regulation of epicardial-mesenchymal transformation during avian heart development.
TL;DR: The results strongly support a model in which myocardially derived FGF-1, -2, or -7 promotes epicardial EMT, while TGFbeta-2, -3 restrains it.
Journal ArticleDOI
Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: the lawrence berkeley laboratory experience
Anthony M. Berson,Anthony M. Berson,Joseph R. Castro,Joseph R. Castro,Paula L. Petti,Theodore L. Phillips,Theodore L. Phillips,Grant E. Gauger,Philip H. Gutin,J. Michael Collier,Sheri D. Henderson,Kari Baken +11 more
TL;DR: Forty-five consecutive patients with chordoma or chondrosarcoma at the base of skull or cervical spine were treated at the University of California Lawrence Berkeley Laboratory (UCLBL) andUniversity of California School of Medicine, San Francisco (UCSF) between November 1977 and October 1986.
Journal ArticleDOI
Genome-wide examination of myoblast cell cycle withdrawal during differentiation.
Xun Shen,J. Michael Collier,Myint Hlaing,Leanne Zhang,Elizabeth H. Delshad,James Bristow,James Bristow,Harold S. Bernstein +7 more
TL;DR: Because C2C12 myoblasts withdraw from the cell cycle during myocyte differentiation following a course that recapitulates this process in vivo, a genome‐wide screen revealed groups of gene products involved in cell cycle withdrawal, muscle differentiation, and apoptosis.
Journal ArticleDOI
Treatment of cancer with heavy charged particles.
Joseph R. Castro,William M. Saunders,Cornelius A. Tobias,George T.Y. Chen,Stanley B. Curtis,John Lyman,J. Michael Collier,Samuel Pitluck,Katherine A. Woodruff,Eleanor A. Blakely,Thomas Tenforde,Devron H. Char,Theodore L. Phillips,Edward L. Alpen +13 more
TL;DR: A clinical radiotherapeutic trial using heavy charged particles in the treatment of human cancers has accrued over 400 patients since 1975, 378 of whom were treated with particles and 28 with low LET photons as control patients.
Journal ArticleDOI
Precision, high dose radiotherapy: helium ion treatment of uveal melanoma.
William M. Saunders,William M. Saunders,Devron H. Char,Jeanne M. Quivey,Joseph R. Castro,Joseph R. Castro,George T.Y. Chen,J. Michael Collier,Aude Cartigny,Eleanor A. Blakely,John Lyman,S.R. Zink,C. A. Tobias +12 more
TL;DR: Clinical results and details of the technique are presented to illustrate potential clinical precision in administering high dose radiotherapy with charged particles such as helium ions or protons in patients with uveal melanoma.